A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma
Author:
Publisher
Elsevier BV
Subject
Oncology,Surgery
Reference29 articles.
1. Cancer statistics;Jemal;CA Cancer J. Clin.,2008
2. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades;Winter;Ann. Surg. Oncol.,2012
3. Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates?;Cooper;J. Gastrointest. Surg.,2015
4. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer;Von Hoff;N. Engl. J. Med.,2014
5. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial;Von Hoff;J. Clin. Oncol.,2011
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immature stroma and high infiltration of CD15+ cells are predictive markers of poor prognosis in different subsets of patients with pancreatic cancer;Cancer Science;2024-01-17
2. FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction;European Journal of Cancer;2024-01
3. A critical review of pancreatectomy with concomitant superior mesenteric artery resection and intestinal autotransplantation;Hepatobiliary Surgery and Nutrition;2023-10
4. Comparison of the upfront surgery and neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: an updated systematic review and meta-analysis;Updates in Surgery;2023-08-28
5. How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review;Cancers;2023-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3